| Kassondra Amada Shoemaker Brino, RN, CPNP-PC | |
|
307 S Salem St Ste 100, Apex, NC 27502-1845 | |
| (919) 627-8771 | |
| Not Available |
| Full Name | Kassondra Amada Shoemaker Brino |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 307 S Salem St Ste 100, Apex, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548746365 | NPI | - | NPPES |
| 68535 | Medicaid | NC |
| Mailing Address | Practice Location Address |
|---|---|
| Kassondra Amada Shoemaker Brino, RN, CPNP-PC 210 Silver Pine Ct, Durham, NC 27713-9266 Ph: (919) 627-8771 | Kassondra Amada Shoemaker Brino, RN, CPNP-PC 307 S Salem St Ste 100, Apex, NC 27502-1845 Ph: (919) 627-8771 |
News Archive
Oxford Nanopore Technologies ("Oxford Nanopore") today announced the publication of new research in Nature Nanotechnology, demonstrating accurate and continuous identification of DNA bases using nanopores.
Australian healthcare company Medical Developments International (MDI) and CSIRO have signed a technology deal to develop a new production process for the drug methoxyflurane - the pain-relieving ingredient used in Penthrox™ (commonly known as the green whistle).
Using an innovative approach to identify a cancer's genetic vulnerabilities by more swiftly analyzing human tumors transplanted into mice, researchers have identified a new potential target for pancreatic cancer treatment, published online in Cell Reports.
Health experts on Monday began a probe of how the WHO responded to the H1N1 (swine flu) pandemic "nearly a year after global alarm was raised over the new swine flu strain," Agence France-Presse reports (Capella, 4/12).
One in eight women in the United States will develop breast cancer. Of those, many will undergo surgery to remove the tumor and will require some kind of breast reconstruction afterward, often involving implants. Cancer is an elusive target, though, and malignant cells return for as many as one-fifth of women originally diagnosed, according to the American Cancer Society.
› Verified 7 days ago